| Term 
 
        | History of Sulfa Drugs (8) |  | Definition 
 
        | 
PRONTOSIL (azo dye) -- 1930 -- I. G. Farbenindustrie This company also made 
ZyklonB for Hitler’s extermination camps  Domagk = research manager 
tested antimicrobial potential in vitro & in vivo determined that a sulfonamide (sulfonilamide) was the active portion of molecule. awarded a Nobel Prize in Medicine in 1938  Foerster – 1933 - first clinical study – 10 month old infant with staph septicemia The 1st effective chemotherapeutic agent |  | 
        |  | 
        
        | Term 
 
        | Overview of Sulfa Drugs (2) |  | Definition 
 
        | 
Single sulfonamides:*Trimethoprim-sulfamethoxazole (TMP-SMX) |  | 
        |  | 
        
        | Term 
 
        | Overview of Sulfa Drugs Single sulfonamides: (7) |  | Definition 
 
        | 
Once the mainstay of chemotherapy but *now less used in US because resistance is increasing. *Still commonly used in under-developed countries because they are cheap & readily available. *Effective against 
many bacteria, several parasites and one fungus  but ineffective against viruses. |  | 
        |  | 
        
        | Term 
 
        | Overview of Sulfa Drugs *Trimethoprim-sulfamethoxazole (TMP-SMX) (4) |  | Definition 
 
        | 
combo Synergistic Very frequently used |  | 
        |  | 
        
        | Term 
 
        | Structure of Sulfonamides Picture Structure of Sulfonamides (4) |  | Definition 
 
        | 
All sulfa drugs are chemical congeners of PABA. *All Sulfas have S-C bond and p-NH2 *5000 synthesized, 150 marketed! *Pathogens are only susceptible if they require PABA to synthesize folic acid. |  | 
        |  | 
        
        | Term 
 
        | Structure of Sulfonamides *5000 synthesized, 150 marketed! (5) |  | Definition 
 
        | 
An example of molecular rouletteThis pioneering work also lead to development of 
sulfonylurea hypoglycemic agents, inhibitors of carbonic anhydrase, & phenazopyridine |  | 
        |  | 
        
        | Term 
 
        | MOA of the Sulfonamides (4) |  | Definition 
 
        | 
*Most are competitive inhibitors of DHPS… But some inhibit indirectly by serving as an *alternative substrate & exhausting the pteridine cofactor. Single sulfas are generally regarded as *bacteriostatic as they prevent new DNA synthesis. *Sulfas are selective for bugs because people use dietary folate |  | 
        |  | 
        
        | Term 
 
        | MOA of the Sulfonamides Picture Development of Resistance to Sulfonamides (4) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Development of Resistance to Sulfonamides (4) |  | Definition 
 
        | 
Can reduce drug uptake or speed its efflux (small multidrug resistance family [SMR]) Can alter drug binding site on DHPS; this can occur even during therapy Can cause overproduction of PABA which is competitive with drug at the active site Can cause development of an alternative path for folate synthesis |  | 
        |  | 
        
        | Term 
 
        | Therapeutic Uses Of Single Sulfa Drugs In General (5) |  | Definition 
 
        | 
*They were widely used in the past for UTIs because:
*Most drug is excreted in active form & concentrated 10-20x in urine which might be bactericidal for some bugs even if not normally recommended at other sites. *But single sulfa drugs are now rarely used for UTIs because: 
Increased resistance among enteric gram (-) bacilli which most frequently cause UTIs. Better agents are now available (TMP-SMX, a fluoroquinolone, fosfomycin, ampicillin |  | 
        |  | 
        
        | Term 
 
        | Therapeutic Uses Of Single Sulfa Drugs In General Single Species (6) |  | Definition 
 
        | 
*In terms of species, single sulfas are backup drugs for 
Mycobacterium fortuitum, Chlamydia trachomatis, Neisseria meningitides, & Nocardia† († but TMP-SMX is now the drug of choice). |  | 
        |  | 
        
        | Term 
 
        | Specific Therapeutic Uses Of Individual Sulfonamides SULFISOXAZOLE (GANTRISIN): ORAL General (3) |  | Definition 
 
        | 
The individual sulfonamides are rarely drugs of first choice with the exceptions cited below.  |  | 
        |  | 
        
        | Term 
 
        | SULFISOXAZOLE (GANTRISIN): ORAL Uses: (7) |  | Definition 
 
        | 
*Used for Rx of uncomplicated UTIs *Alternate for: 
Chlamydia, Mycobacterium fortuitum, Nocardia, Neisseria meningitidis  *Ineffective for CNS infections because of its low lipid solubility |  | 
        |  | 
        
        | Term 
 
        | SULFAMETHOXAZOLE (GANTANOL): ORAL (5) |  | Definition 
 
        | 
*Similar to sulfisoxazole but: 
It is more slowly absorbed and excreted *It has a longer t½ (11 hr) *It is more likely to cause crystalluria *Reminder: It is usually marketed with trimethoprim in TMP-SMX |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
*Achieves highest concentration in CSF (30-80% of [plasma]) Relatively rapidly absorbed & excreted *Its use is limited by crystalluria!!! 
*Urine flow must be brisk (>1.2 L/day in adults) *Bicarbonate reduces renal tubular reabsorption and thereby accelerates renal clearance. |  | 
        |  | 
        
        | Term 
 
        | SULFASALAZINE (AZULFIDINE): (8) |  | Definition 
 
        | 
POORLY ABSORBED ORAL DRUG *One of top 300 drugs *Mostly held in GI tract/bowel & excreted in feces *Used for inflammatory bowel disease (IBD), ulcerative colitis, regional enteritis bec. of antiinflammatory properties. It is a *prodrug Sulfasalazine ▬► Sulfapyridine + 5-aminosalicylate (5AS) *5AS (mesalamine) is an active antiinflammatory compound that inhibits cyclooxygenase *A comparable concentration of mesalamine in the colon cannot otherwise be obtained. *Sulfapyridine can cause systemic toxic effects |  | 
        |  | 
        
        | Term 
 
        | SILVER SULFADIAZINE (SILVADENE): (6) |  | Definition 
 
        | 
TOPICAL *Agent of choice for prevention of infections in 2nd & 3rd degree burns 
*Silver released is a broad-spectrum agent x bacteria and fungi. *It reduces colonization, prevents sepsis, & encourages healing but is *not useful against established deep infections. *It is used topically on burns with little toxicity. *Systemic absorption is possible when applied to a large area. |  | 
        |  | 
        
        | Term 
 
        | SULFACETAMIDE (SULAMYD) (5) |  | Definition 
 
        | 
A topical opthalmic *It is used for Rx of many sulfonamide- sensitive ophthalmic infections.*It is an impt. alternate for Chlamydia trachomatis. *High concentrations (30%) aren’t irritating or allergenic & are of neutral pH *It readily penetrates ocular fluids and tissues. |  | 
        |  | 
        
        | Term 
 
        | Pharmacokinetics Of Sulfonamides (5) |  | Definition 
 
        | 
*Most are well absorbed orally (70-95%) *Most are widely distributed including into the CSF, fetus (but sulfadiazine best for CSF) *Acetylation occuring in liver inactivates & decreases solubility which increases crystallization. *Elimination is by glomerular filtration so renal function is required. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
*Crystals of sulfonamide & acetylated sulfonamide can cause renal damage [Least common with sulfisoxazole.] *Most common with sulfadoxine used for prophylaxis of malaria with pyrimethamine (Remember fluids, bicarbonate!) *Must use reduced dosage (or cease use) if kidney function is impaired. |  | 
        |  | 
        
        | Term 
 
        | Sulfas: Hypersensitivity Reactions Frequent (3) |  | Definition 
 
        | 
*Drug Fever (3% w sulfisoxazole) *Skin Rashes (2%) during 1st wk *Photosensitivity |  | 
        |  | 
        
        | Term 
 
        | Sulfas: Hypersensitivity Reactions Occasional but Serious: (4) |  | Definition 
 
        | 
*Erythema multiforme (Stevens-Johnson syndrome): the most serious sulfa rash 
It can cause exfoliation It occurs very infrequently It can occur with any sulfa drug but occurs most often with long-acting sulfas |  | 
        |  | 
        
        | Term 
 
        | Sulfas: Other Toxicities & Drug Interactions (8) |  | Definition 
 
        | 
*Hematopoietic anemia or abnormalities: occasional serious blood dyscrasias including agranulocytosis (0.1%) Vasculitis (opccasional) Hepatotoxicity (occasional; 0.1%) *Kernicterus (occasional) 
Displaces bilirubin from albumin Shouldn’t be given to near-term women Also, keep in mind that sulfas are secreted in milk of nursing moms  Pregnancy: FDA Recommendation “C” but contraindicated near term |  | 
        |  | 
        
        | Term 
 
        | Structure Of Trimethoprim |  | Definition 
 
        | *Used x bacteria parasites some fungi |  | 
        |  | 
        
        | Term 
 
        | Structure of Trimethoprim Trimethoprim |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Structure of Trimethoprim Pyrimethamine Mechanism of TMP-SMX (2) |  | Definition 
 
        | 
*TMP/PMA [trimethoprim or pyrimethamine] competitively inhibits DHFR by binding to the active site for dihydrofolic acid. *The simultaneous presence of SMX in TMP/SMX *potentiates action of TMP/PMA by ↓ the concentration of dihydrofolic acid. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
*TMP/PMA [trimethoprim or pyrimethamine] competitively inhibits DHFR by binding to the active site for dihydrofolic acid. *The simultaneous presence of SMX in TMP/SMX *potentiates action of TMP/PMA by ↓ the concentration of dihydrofolic acid |  | 
        |  | 
        
        | Term 
 
        | Mechanism of TMP-SMX Structure |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Specificity of Inhibitors of Dihydrofolate |  | Definition 
 
        | Specificity of Inhibitors of Dihydrofolate |  | 
        |  | 
        
        | Term 
 
        | Antifolate: (3) Trimethoprim Alone (Proloprim) |  | Definition 
 
        | x cancer, x autoimmune diseases, for induction of abortions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Only marketed for oral Rx of uncomplicated UTIs caused by gm(-) bacilli. Can result in resistance to this drug and to trimethoprim-sulfamethoxazole. Resistance to TMP alone occurs by: 
Alteration of dihydrofolate reductase Reduced permeability Conversion to thymidine dependence |  | 
        |  | 
        
        | Term 
 
        | Major Rx Uses of TMP-SMX General (6) |  | Definition 
 
        | 
*Med Lett drug of choice for 11 organisms including: 
Gram-negative bacilli (5) Actinomycetes (2) Parasites (3) One fungus (*Pneumocystis jiroveci; formerly called P. carinii ) *An important backup drug for 17 other organisms. |  | 
        |  | 
        
        | Term 
 
        | Major Rx Uses of TMP-SMX (4) |  | Definition 
 
        | 
*Oral Rx of UTIs & Prostatis *Bacterial Respiratory Tract Infections *GI Infections: *MRSA |  | 
        |  | 
        
        | Term 
 
        | Major Rx Uses of TMP-SMX *Oral Rx of UTIs & Prostatis (3) |  | Definition 
 
        | 
Especially useful for recurrent UTIs Bacterial prostatis Used as a backup to FQs |  | 
        |  | 
        
        | Term 
 
        | Major Rx Uses of TMP-SMX *Bacterial Respiratory Tract Infections (3) |  | Definition 
 
        | 
Otitis media in kids Sinusitis in adults Acute chronic bronchitis |  | 
        |  | 
        
        | Term 
 
        | Major Rx Uses of TMP-SMX *GI Infections: (4) |  | Definition 
 
        | 
Shigellosis (backup to FQs) Traveler’s diarrhea Enterohemorrhagic E. coli O157:H7 
BUT Rx can ↑ risk of hemolytic–uremic syndrome |  | 
        |  | 
        
        | Term 
 
        | Major Rx Uses of TMP-SMX *MRSA (3) |  | Definition 
 
        | 
Methicillin-resistant Staph aureus (MRSA) infections Only used as a backup, limited experience  |  | 
        |  | 
        
        | Term 
 
        | Major Rx Uses of TMP-SMX AIDs Patients Bacterial Infections (4)   |  | Definition 
 
        | 
*Treatment of choice for 3 parasitic infections especially prevalent in AIDS patients.
*Cyclospora cayetanensis (cyclosporiasis) *Isospora belli diarrhea (IV) (isosporiasis) *Toxoplasmosis (actually pyrimethamine + sulfadiazine + leucovorin (10-25 mg with each dose of pyrimethamine)) |  | 
        |  | 
        
        | Term 
 
        | Major Rx Uses of TMP-SMX AIDs Patients Fungal Infections (3) |  | Definition 
 
        | 
*Treatment of choice for one fungal infection especially common in AIDS patients 
*Pneumocystis jiroveci pneumonia (“PCP”: IV); both treatment and prophylaxis Listed as a parasite in the Med. Letter Handbook; formerly called P. carini |  | 
        |  | 
        
        | Term 
 
        | Toxicity of TMP-SMX General (2) |  | Definition 
 
        | 
*Drug-induced glossitis (inflam. of the tongue) and/or stomatitis (inflam. of the mucous membranes in the mouth) are not uncommon! BUT DRUG-INDUCED ANGIOEDEMA IS RARELY THIS BAD! |  | 
        |  | 
        
        | Term 
 
        | Toxicity of TMP-SMX Overview (6) |  | Definition 
 
        | 
*Other hypersensitivity reactions, *Skin problems *CNS *Crystalluria *Anti-folate effects Also includes toxicities listed for sulfonamides alone. |  | 
        |  | 
        
        | Term 
 
        | Toxicity of TMP-SMX *Other hypersensitivity reactions, (6) |  | Definition 
 
        | 
include 
fever, rashes, photosensitivity, leukopenia, & diarrhea (esp. in AIDS pts). |  | 
        |  | 
        
        | Term 
 
        | Toxicity of TMP-SMX *Skin problems (2) |  | Definition 
 
        | 
3x more likely than with SMX alone; especially common in the elderly |  | 
        |  | 
        
        | Term 
 
        | Toxicity of TMP-SMX *CNS (4) |  | Definition 
 
        | 
rare: 
headache, depression, hallucinations |  | 
        |  | 
        
        | Term 
 
        | Toxicity of TMP-SMX *Crystalluria (1) |  | Definition 
 
        | 
is rare but the combo is contraindicated in pts w ⬇⬇ renal function as it can cause permanent kidney damage. |  | 
        |  | 
        
        | Term 
 
        | Toxicity of TMP-SMX *Anti-folate effects (6) |  | Definition 
 
        | 
anemia, leukopenia, thrombocytopenia are: blocked by 
coadministration of folinic acid without loss of antimicrobial action. rare unless patient is folate deficient |  | 
        |  | 
        
        | Term 
 
        | Specific Therapeutic Uses Of Individual Sulfonamides SULFISOXAZOLE (GANTRISIN): ORAL General (3) |  | Definition 
 
        | 
*The Oral Sulfonamide Of Choice *Very soluble in water so unlikely to cause crystalluria *However, has the shortest t½ (ca 5-6 hr)
Specific Therapeutic Uses Of Individual Sulfonamides  |  | 
        |  | 
        
        | Term 
 
        | Drug Resistance to TMP-SMX (3) |  | Definition 
 
        | 
*Resistance is less common than against a single sulfonamide 
Two genetic changes must take place. It can occur via plasmid transfer. |  | 
        |  |